NDC 70518-3548

Rexulti

Brexpiprazole

Rexulti is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Brexpiprazole.

• Product ID: 70518-3548_ea235ac9-75e5-b1be-e053-2995a90a2e4e
• NDC: 70518-3548
• Product Type: Human Prescription Drug
• Proprietary Name: Rexulti
• Generic Name: Brexpiprazole
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2022-10-03
• Marketing Category: NDA /
• Application Number: NDA205422
• Labeler Name: REMEDYREPACK INC.
• Substance Name: BREXPIPRAZOLE
• Active Ingredient Strength: 2 mg/1
• Pharm Classes: Atypical Antipsychotic [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 70518-3548-0

1 BOTTLE in 1 CARTON (70518-3548-0) > 30 TABLET in 1 BOTTLE

• Marketing Start Date: 2022-10-03
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Rexulti" or generic name "Brexpiprazole"

NDC	Brand Name	Generic Name
59148-035	Rexulti	brexpiprazole
59148-036	Rexulti	brexpiprazole
59148-037	Rexulti	brexpiprazole
59148-038	Rexulti	brexpiprazole
59148-039	Rexulti	brexpiprazole
59148-040	REXULTI	REXULTI